Zimmer Biomet Holdings, Inc. (ZBH)

NYSE: ZBH · IEX Real-Time Price · USD
108.87
+2.47 (2.32%)
Jun 24, 2022 4:04 PM EDT - Market closed
2.32%
Market Cap 22.82B
Revenue (ttm) 7.65B
Net Income (ttm) 217.70M
Shares Out 209.58M
EPS (ttm) 1.04
PE Ratio 104.78
Forward PE 15.60
Dividend $0.96 (0.88%)
Ex-Dividend Date Jun 24, 2022
Volume 1,580,812
Open 107.53
Previous Close 106.40
Day's Range 105.61 - 109.20
52-Week Range 101.22 - 162.71
Beta 1.16
Analysts Hold
Price Target 133.57 (+22.7%)
Earnings Date Aug 2, 2022

About ZBH

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate ... [Read more...]

Industry Health Care Equipment & Supplies
Founded 1927
CEO Bryan Hanson
Employees 19,500
Stock Exchange NYSE
Ticker Symbol ZBH
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 30 analysts, the average rating for ZBH stock is "Hold." The 12-month stock price forecast is 133.57, which is an increase of 22.69% from the latest price.

Price Target
$133.57
(22.69% upside)
Analyst Consensus: Hold
Stock Forecasts

News

Zimmer (ZBH) Down 5.6% Since Last Earnings Report: Can It Rebound?

Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock?

Zimmer Biomet Announces Appointment of Keri P. Mattox as Chief Communications and Administration Officer

Expanded Role Adds Responsibility for Environmental, Social and Governance (ESG) Strategy and Office of the CEO to Portfolio WARSAW, Ind. , May 26, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYS...

Here's Why Investors Should Retain Zimmer Biomet (ZBH) Now

Investors are optimistic about Zimmer Biomet's (ZBH) better-than-expected revenues and robust performance across several geographies.

Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2022

WARSAW, Ind. , May 17, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of ...

Zimmer Biomet Announces Appointment of New Chief Accounting Officer

Paul Stellato Joins Zimmer Biomet as Vice President, Controller and Chief Accounting Officer WARSAW, Ind. , May 16, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medica...

Zimmer Biomet Debuts First-of-its-Kind Artificial Intelligence Capabilities for Omni™ Suite Intelligent Operating Room

Artificial Intelligence-Based Object Recognition Automates Manual Tasks and Data Collection to Optimize Operating Room Workflow Efficiency WARSAW, Ind. , May 10, 2022 /PRNewswire/ -- Zimmer Biomet Holdi...

Zimmer Biomet's (ZBH) Procedure Volume Grows, Costs Rise

Zimmer Biomet's (ZBH) recently completed the spin-off of the non-core dental and spine business is expected to prove strategic.

Zimmer Biomet Raises, Tightens FY22 Outlook after Q1 Earnings Surpass Estimates

Zimmer Biomet Holdings Inc's (NYSE: ZBH) Q1 sales increased by 3.9% Y/Y to $1.66 billion (up 6.8% on a constant currency basis), beating the consensus of $1.59 billion. Adjusted EPS was $1.61, which cam...

Zimmer Biomet (ZBH) Q1 Earnings Top Estimates, FY22 View Up

Each of Zimmer Biomet's (ZBH) geographic segments and product divisions recorded year-over-year sales growth at CER.

Zimmer Biomet (ZBH) Q1 Earnings and Revenues Surpass Estimates

Zimmer (ZBH) delivered earnings and revenue surprises of 15% and 4.10%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zimmer Biomet Announces First Quarter 2022 Financial Results

First quarter net sales from continuing operations of $1.663 billion increased 3.9% and 6.8% on a constant currency1 basis First quarter diluted earnings per share from continuing operations were $0.35;...

Is a Surprise Coming for Zimmer Biomet (ZBH) This Earnings Season?

Zimmer Biomet (ZBH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zimmer Biomet to Present at the BofA Securities Healthcare Conference

WARSAW, Ind., April 27, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Chairman, President and CEO Bryan Hanson and Execu...

Zimmer Biomet (ZBH) Expected to Beat Earnings Estimates: Should You Buy?

Zimmer (ZBH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zimmer Biomet (ZBH) to Report Q1 Earnings: What's in Store?

Zimmer Biomet (ZBH) might have struggled to maintain the recovery trend in the first half of Q1 with severe-than-expected staffing shortages and supply issues leading to procedural deferrals.

3 Medical Product Stocks Poised to Beat This Earnings Season

Medical product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how ALC, ZBH and CSII are poised ahead of their earnings releases.

Other symbols: ABTALCCSIIISRG

Here's Why You Should Retain Zimmer Biomet (ZBH) Stock For Now

Investors are optimistic about Zimmer Biomet (ZBH) given robust demand for its ROSA robotics line and continued investment in profitable business areas.

Extremity Medical Files Patent Infringement Lawsuit Against Nextremity Solutions, Zimmer Biomet Holdings and Zimmer, ...

PARSIPPANY, N.J.--(BUSINESS WIRE)--Extremity Medical files patent infringement lawsuit against Nextremity Solutions, Zimmer Biomet Holdings and Zimmer, Inc.

Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2022 Financial Results

WARSAW, Ind. ,  April 5, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its first quarter earnings conference call will be webcast on Tuesday, May 3, 2022 at 8:30 ...

Zimmer Biomet (ZBH) Hurt by China VBP, COVID-Led Staff Shortage

Zimmer Biomet (ZBH) expects to face an adverse pricing impact in the first half of 2022, which is being compared to the non-VBP first half of 2021.

7 Dividend Stocks to Avoid in the Rotation to Safety

It's just as important to know what dividend stocks to avoid as it is to know which ones to buy, especially in the current market. The post 7 Dividend Stocks to Avoid in the Rotation to Safety appeared ...

Other symbols: AGNCFTVMTNNHIPEGASBRA

Zimmer Biomet: Short-Term Issues, Long-Term Growth Opportunities

Zimmer Biomet ( ZBH , Financial) is a global leader in musculoskeletal health care. The company designs, manufactures and markets orthopedic reconstructive implants and supplies surgical equipment for o...

Zimmer Biomet (ZBH) New WalkAI Model to Bolster Robotics Arm

WalkAI adds powerful predictive analytic capabilities to ZBEdge, Zimmer Biomet's (ZBH) suite of integrated digital and robotic technologies.

Zimmer Biomet Debuts WalkAI™ Artificial Intelligence Model to Predict Post-Operative Recovery Progress

WARSAW, Ind. , March 10, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the release of WalkAI™, a dynamic artificial intellige...

Zimmer (ZBH) Down 3.5% Since Last Earnings Report: Can It Rebound?

Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock?